Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 clinical study of NMRA-898, a structurally distinct M4 Positive Allos…
Bird Flu Strain H9N2: A Potential Threat to Humans A team of scientists has found that the H9N2 bird flu virus, often considered a minor s…
Market Update The Australian stock market is experiencing a decline, led by heavy falls in the healthcare and tech sectors, despite seven …
Rolls-Royce Achieves World First with Methanol Engine Rolls-Royce Power Systems has successfully tested a high-speed marine engine powered…
OnePlus 15: Hasselblad Replaced by DetailMax Engine The upcoming release of the OnePlus 15 will no longer feature the Hasselblad branding …
Community Pharmacies and BioPharma: Advancing Whole-Patient Care Together The healthcare landscape has never been more complex, with the p…
Designing Light-Filled Living Spaces In Florida, natural light is one of the state’s most abundant resources—and homeowners are increasing…
Rolex 24 Grid Expansion Not Possible Due to Pit Lane Space IMSA President John Doonan stated that accommodating more cars for the Rolex 24…
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial Zenas BioPharma, a clinical-stage global biopharmaceutical company…
Utah's Olympic Organizers in NYC Leaders of Utah's 2034 Winter Games are in New York City to show support for American athletes competing …
Abbott Directed to Provide Prescribing Details for Triamcinolone Hexacetonide Pre-Filled Syringe The Subject Expert Committee (SEC) under …